<DOC>
	<DOCNO>NCT01235195</DOCNO>
	<brief_summary>This study design determine difference drug exposure subject administer 50 mg tablet sertraline hydrochloride compare drug exposure administer 50 mg capsule sertraline hydrochloride fast ( nonfed ) condition .</brief_summary>
	<brief_title>A Study Comparing Drug Exposure Humans After Administration 50 mg Tablet Sertraline Hydrochloride Compared 50 mg Capsule Sertraline Hydrochloride Under Fasted ( Nonfed ) Conditions</brief_title>
	<detailed_description />
	<mesh_term>Sertraline</mesh_term>
	<criteria>Healthy male and/or female subject age 21 55 year , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 45 kg ( 99 lb ) . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) . Any condition possibly affect drug absorption ( eg , gastrectomy )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>bioequivalence study</keyword>
	<keyword>sertraline 50 mg</keyword>
	<keyword>capsule vs tablet</keyword>
</DOC>